Molecular imprinted macroporous chitosan coated mesoporous silica xerogels for hemorrhage control

Biomaterials
Chenglong DaiQinghui Zhao

Abstract

Efficacious hemostatic agents have significant potential for use in rapid exsanguinating hemorrhage control by emergency medical technician or military medic nowadays. Unfortunately, the topical hemostats currently available in market still have various disadvantages. In this study, a series of macroporous chitosan coated mesoporous silica xerogel beads (CSSX) with good biocompatibility were developed. They consisted of mesoporous silica xerogel cores and chitosan layers with macroporous structure by using modified sol-gel process and PEG molecular imprinting technique. The textural properties of the CSSX beads were optimized by in vitro and in vivo evaluation for promoting blood clotting and the results indicated that the prepared CSSX beads can significantly accelerate the contact activation pathway of coagulation cascade and produce desirable hemostasis, with the best efficiency from the CSSX prepared with 2% chitosan and 5% PEG. Furthermore, these CSSX beads were observed to create no exothermic reaction and the subsequential tissue thermal injury by histological examination, and exhibited no obvious cytotoxicity even after 7 days. The results of the present study forward CSSX bead as a safe hemostatic system and present a ...Continue Reading

References

Jan 5, 2002·Journal of Biomedical Materials Research·Pamela J VandeVordPaul H Wooley
Jun 19, 2003·The Journal of Trauma·Hasan B AlamPeter Rhee
Sep 18, 1964·Science·E W DAVIE, O D RATNOFF
Dec 31, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·S Sh RashidovaB D Kabulov
Aug 16, 2005·Biomaterials·Zhe GuoChristopher A Siedlecki
Mar 15, 2006·The Journal of Trauma·Anthony E PusateriKathy L Ryan
Jun 21, 2006·Journal of Thrombosis and Thrombolysis·Todd A OstomelGalen D Stucky
Sep 27, 2006·Journal of Biomedical Materials Research. Part a·Thomas H FischerJohn N Vournakis
Jan 12, 2007·The Journal of Trauma·Bijan S KheirabadiJohn B Holcomb
May 22, 2007·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Jian YangShi-Qian Chen
Sep 26, 2007·Langmuir : the ACS Journal of Surfaces and Colloids·Todd A OstomelGalen D Stucky
Jan 24, 2008·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Buddy G KozenAndrew S Johnson
Apr 12, 2008·The Journal of Trauma·Peter RheeHassan Alam
Sep 3, 2008·The British Journal of Surgery·H SeyednejadA M Seifalian
Oct 14, 2008·The Journal of Trauma·Michael S EnglehartMartin A Schreiber
Nov 26, 2008·Biomaterials·Eun-Jung LeeJun-Hyeog Jang
Mar 27, 2009·Annals of Emergency Medicine·Michael KilbourneGrant V Bochicchio

❮ Previous
Next ❯

Citations

Apr 9, 2013·Journal of Biomaterials Science. Polymer Edition·Liangxin XuYen Wei
Mar 30, 2012·International Journal of Nanomedicine·Hong LiYonggang Yan
May 8, 2014·Colloids and Surfaces. B, Biointerfaces·Pedro Melgar-LesmesMaría José García-Celma
Jan 7, 2016·Journal of Biomaterials Science. Polymer Edition·Caihong LeiJianyong Chen
May 25, 2016·Trauma Monthly·Hadi KhoshmohabatBehnam Dalfardi
Mar 16, 2016·ACS Applied Materials & Interfaces·Kecheng QuanXing Wang
Feb 8, 2011·Biotechnology Journal·G Kevin HydeRoger J Narayan
Dec 7, 2013·Journal of Biomedical Materials Research. Part a·Adam M BehrensPeter Kofinas
Apr 5, 2014·Journal of Molecular Recognition : JMR·Michael J WhitcombeIan A Nicholls
May 24, 2015·Colloids and Surfaces. B, Biointerfaces·Kecheng QuanXing Wang
May 25, 2016·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Ji-Ung ParkSukwha Kim
Oct 31, 2018·Biomaterials Science·Sara PourshahrestaniMark R Towler
Oct 26, 2018·Biomaterials Science·Chengwei WangChangsheng Liu
Jun 5, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Caiyun ZhengTingli Lu
Dec 31, 2011·Journal of Biomaterials Applications·Qing HeXiufang Zhang
Nov 8, 2019·Advanced Healthcare Materials·Xiao-Xiong WangYun-Ze Long
Jan 7, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Sara PourshahrestaniMark R Towler
Feb 15, 2017·Annals of Plastic Surgery·Niann-Tzyy DaiTim-Mo Chen
May 21, 2015·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Fangping ChenChangsheng Liu
Dec 21, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Jing LiChao Feng
Aug 23, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Jianwei ZhangQifa Ye
Nov 28, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Zihao ChenFeng Tian
Dec 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zhang HuLei Yang
Jan 27, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Xiao YangChangcan Shi
Jan 30, 2021·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Annum MalikSara Qaisar
Jun 27, 2021·International Journal of Biological Macromolecules·Balaram MishraDevendra Verma
Feb 21, 2018·ACS Applied Materials & Interfaces·Constanza MelladoKatherina Fernández
Dec 22, 2016·ACS Applied Materials & Interfaces·Chao FengXi Guang Chen
Oct 17, 2020·Journal of Biomaterials Applications·Malvika NagrathMark R Towler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Guoming SunSharon Gerecht
Critical Care Medicine
Jeremy G PerkinsCharles E Bolan
Annals of Plastic Surgery
Joseph E LoseeJoseph M Serletti
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society
Viviane Fernandes de CarvalhoMarcus Castro Ferreira
Journal of Biomedical Materials Research. Part a
Paola LaurienzoLuisa Mannina
© 2021 Meta ULC. All rights reserved